首页> 外文期刊>Tumour biology : >ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells
【24h】

ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells

机译:ZNRF3在甲状腺乳头状癌中被下调并抑制甲状腺乳头状癌细胞的增殖和侵袭

获取原文
获取原文并翻译 | 示例
       

摘要

Zinc and ring finger 3 (ZNRF3) is a transmembrane E3 ubiquitin ligase that has emerged as an important regulator of cancer development; however, its cancer-related function remains controversial. Here, we investigated the possible role of ZNRF3 in thyroid carcinoma (TC). We found that ZNRF3 is downregulated in papillary thyroid carcinoma (PTC) compared to normal thyroid tissues and inversely correlated with the degree of cell differentiation. Overexpression of ZNRF3 significantly suppressed cell malignant behaviors, including cell proliferation, migration, and invasion in vitro, as well as tumor growth in vivo. Consistent with recent studies showing that ZNRF3 is involved in the Wnt/beta-catenin pathway, ZNRF3 overexpression negatively regulated beta-catenin activation, modulating PTC cell behaviors. Clinical specimens revealed a significant inverse correlation between ZNRF3 and beta-catenin mRNA levels. Taken together, these results provide insight into a potential tumor suppressor role of ZNRF3 in PTC progression, and may have potential clinical relevance for the prognosis and treatment of PTC.
机译:锌和无名指3(ZNRF3)是一种跨膜E3泛素连接酶,已成为癌症发展的重要调节剂。然而,其与癌症相关的功能仍存在争议。在这里,我们调查了ZNRF3在甲状腺癌(TC)中的可能作用。我们发现与正常甲状腺组织相比,ZNRF3在乳头状甲状腺癌(PTC)中被下调,并且与细胞分化程度成反比。 ZNRF3的过表达显着抑制细胞恶性行为,包括体外细胞增殖,迁移和侵袭以及体内肿瘤生长。与最近的研究表明ZNRF3参与Wnt /β-catenin途径一致,ZNRF3的过表达负调控β-catenin的活化,调节PTC细胞的行为。临床标本显示ZNRF3与β-cateninmRNA水平之间呈显着负相关。综上所述,这些结果提供了ZNRF3在PTC进展中潜在的抑癌作用的见解,并且可能与PTC的预后和治疗具有潜在的临床相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号